Deadly cholera outbreak in Malawi claims 1,210 lives: WHO
The deadliest outbreak of cholera in the history of Malawi, a landlocked country in southeastern Africa, has claimed 1,210 lives, according to the
Drugs
Pharma
Abbott to acquire Cardiovascular Systems for $890 million
Abbott Laboratories has agreed to buy medical device maker Cardiovascular Systems for about $890 million.
Drugs
Pharma
Lupin gets FDA nod for injection to lessen saliva, stomach acid
Lupin Limited, an Indian maker of branded, generic formulations, biotechnology products, and active pharmaceutical ingredients, has got USFDA approval for its ANDA injection,
Drugs
Pharma
CVS set to acquire Oak Street Health for $10.6 billion in cash
CVS Health, a US healthcare company, is set to acquire Oak Street Health in an all-cash deal valued at $10.6 billion, according to
Climate
Drugs
Pharma
H5N1 influenza’s spread to mammals needs ‘close monitoring’
A recent spillover to mammals of H5N1 avian influenza needed to be “monitored closely” as the WHO readies vaccines and antivirals and urged
Climate
Health
Time running out for quake survivors in Turkey, Syria
Time was running out for the survivors of the earthquakes that struck Turkey and Syria as health agencies and organisations called for urgent
Health
Medical
WHO boss Tedros wants to ‘banish’ trans fats
Nine of the 16 countries with the highest estimated proportion of coronary heart disease deaths caused by trans fat still do not have
Climate
Medical
Global leaders lack long-term vision on climate action, nuclear threats: UN chief says
Global politicians and decision-makers lack a long-term vision on climate action, financing debt of lower-income nations, cultural rights and rising nuclear threats, the
Drugs
Medical
Pharma
Blood cancer therapy may help to treat ovarian cancer: Swedish scientists
A cell therapy currently used to treat blood cancers can lead to clinical studies for ovarian cancer, scientists from one of the world’s
Drugs
Pharma
Global Pharma recalls eye drops after FDA contamination warning
India-based Global Pharma Healthcare voluntarily recalled all lots of its artificial tears lubricant eye drops after the USFDA reported possible contamination.